This episode explores the ongoing efforts to align regulatory standards for drug approvals globally and their significant impact on the pharmaceutical landscape. We discuss the challenges posed by diverse regulatory requirements across different countries and the historical context that led to the formation of the International Council for Harmonization (ICH). We examine the roles of key regulatory agencies, including the FDA, EMA, and PMDA, and how the ICH facilitates collaboration and consensus-building among them. We also delve into how harmonization efforts impact various stages of drug development, from preclinical studies to clinical trials and the final approval process. Join us as we explore the benefits and challenges of global regulatory harmonization.

This episode further explores the practical benefits of regulatory harmonizatio ...